It actually could be. At least, there is a link found between two of them.

A recent Danish study suggests that using menopausal hormone therapy could be connected to a higher risk of dementia and Alzheimer’s.

The researchers discovered that both long-term users of menopausal hormone therapy and those who used it around the age of menopause (>55 years old) had an increased risk of developing dementia.

To be more specific, people who used estrogen-progestin therapy (a type of menopausal hormone therapy) had a 24% higher risk of developing dementia or Alzheimer’s compared to those who never used it.

Another remarkable finding was that the risk increased with longer use – from 21% for 1 year or less to 74% for more than 12 years of use.

It is worth mentioning, that the type of therapy (continuous or cyclic) and using progestin-only therapy or vaginal estrogen only didn’t seem to make a significant difference in the risk.

To come to these findings, the researchers looked at 5,589 cases of dementia and included for comparison 55,890 people who were dementia-free.

Please, notice, this study is observational, which means it can’t prove cause and effect. It can only show a link.

Curious? HERE is the source